Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001398432-21-000007
Filing Date
2021-02-05
Accepted
2021-02-05 17:03:20
Documents
94
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 a14261.htm 10-K 1080515
2 SECTION 302 CERTIFICATION exh31_1.htm EX-31.1 10476
3 SECTION 906 CERTIFICATION exh32_1.htm EX-32.1 4101
  Complete submission text file 0001398432-21-000007.txt   8952690

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE nphc-20181231.xml EX-101.INS 1330717
5 XBRL SCHEMA FILE nphc-20181231.xsd EX-101.SCH 104728
6 XBRL CALCULATION FILE nphc-20181231_cal.xml EX-101.CAL 29994
7 XBRL DEFINITION FILE nphc-20181231_def.xml EX-101.DEF 468420
8 XBRL LABEL FILE nphc-20181231_lab.xml EX-101.LAB 672478
9 XBRL PRESENTATION FILE nphc-20181231_pre.xml EX-101.PRE 475814
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

EIN.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-32141 | Film No.: 21596991
SIC: 2833 Medicinal Chemicals & Botanical Products